Clinical trials and NL
Despite the severity and pertinence of action required once someone is diagnosed with NL, recommendations and data explaining how to do so is severely lacking. Neurolymphomatosis is extremely hard to diagnose, and sometimes harder to treat, due to the lack of information on the condition. Symptoms can vary for each patient, and scans such as MRI are only somewhat reliable. PET scans have been found to be the best bet for diagnosing NL if no other tests are conclusive.